XRCC1 and lung carcinoma: Sensitivity analysis showed that changing the effect models had no significant effects on the pooled OR and HR, and did not change the final strength of the association between the XRCC1 Arg194Trp and Arg399Gln polymorphisms and sensitivity to platinum-based chemotherapy for advanced lung cancer patients.